Global Neurotechnology Market is Projected to Cross USD 50 Billion by 2034 | DelveInsight

The global neurotechnology market is witnessing robust growth, driven by increasing demand for innovative solutions to diagnose, monitor, and treat neurological disorders. Advances in brain-computer interfaces (BCIs), neurostimulation devices, neuroimaging technologies, and AI-powered neuroscience tools are expanding both clinical and research applications. Rising investments from medical device companies, startups, and government initiatives are further accelerating innovation and commercialization. 

LAS VEGAS, July 6, 2026 /PRNewswire/ — DelveInsight’s Neurotechnology Market Insights report provides the current and forecast market analysis, individual leading neurotechnology companies’ market shares, challenges, neurotechnology market drivers, barriers, trends, and key neurotechnology companies in the market.

Neurotechnology Market Summary

• 2025 Neurotechnology Market Size: USD 17.2 Billion
• 2034 Projected Neurotechnology Market Size: USD 57 Billion
• Neurotechnology Market Growth Rate (2026-2034): ~14% 
• Largest Neurotechnology Market: North America
• Largest Product Type Segment: Neurostimulation Devices Category
• Key Companies in the Neurotechnology Market: Neuralink Corp., Synchron Inc., Paradromics Inc., Blackrock Neurotech LLC, Kernel Inc., Emotiv Inc., NeuroSky Inc., OpenBCI Inc., Neurable Inc., BrainCo Inc., NextMind (Snap Inc.), Bitbrain Technologies S.L., Advanced Brain Monitoring Inc., Cognionics Inc., g.tec medical engineering GmbH, Natus Medical Incorporated, Nihon Kohden Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and others

To read more about the latest highlights related to the neurotechnology market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/neurotechnology-market

Key Factors Contributing to the Rise in Growth of the Neurotechnology Market

• Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, stroke, and multiple sclerosis is driving demand for advanced neurotechnology solutions. Growing patient populations have increased the need for accurate diagnosis, effective treatment, and long-term neurological monitoring.
• Rapid Advancements in Brain-Computer Interface (BCI) Technology: Continuous innovations in brain-computer interfaces are expanding applications beyond research into healthcare, rehabilitation, communication, and consumer electronics. Improved signal processing, AI integration, and wireless technologies are accelerating commercialization and adoption.
• Growing Adoption of Minimally Invasive Neurostimulation Devices: Healthcare providers are increasingly utilizing minimally invasive neurostimulation therapies, including deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). These technologies offer effective symptom management with reduced recovery time and improved patient outcomes.
• Rising Investments in Neuroscience Research and Development: Governments, research institutions, and private investors are significantly increasing funding for neuroscience and neurotechnology innovation. This investment supports the development of next-generation diagnostic tools, implantable devices, and precision therapies for neurological disorders.
• Expansion of Artificial Intelligence in Neurological Diagnostics: Artificial intelligence and machine learning are enhancing the accuracy and speed of brain imaging analysis, neurological disease detection, and predictive diagnostics. AI-enabled neurotechnology platforms improve clinical decision-making while enabling personalized treatment strategies.
• Increasing Demand for Mental Health Solutions: Growing awareness of mental health disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD) has fueled demand for neurotechnology-based therapies. Non-invasive brain stimulation and neurofeedback systems are emerging as effective alternatives or complements to traditional treatments.
• Growing Geriatric Population Worldwide: Aging populations are more susceptible to neurodegenerative diseases and cognitive decline, creating sustained demand for neurological diagnostics, monitoring devices, and therapeutic technologies. This demographic trend continues to expand the addressable market for neurotechnology companies.
• Technological Advancements in Neuroimaging Systems: Continuous improvements in MRI, EEG, MEG, PET, and functional neuroimaging technologies are enabling earlier disease detection and better understanding of brain function. Enhanced imaging capabilities support both clinical practice and neuroscience research.
• Increasing Use of Wearable and Portable Neurotechnology Devices: Wearable EEG headsets, portable neurostimulation systems, and digital neuro-monitoring devices are making neurological assessment more accessible outside hospital settings. Their adoption supports remote patient monitoring, home-based care, and continuous data collection.

Get a sneak peek at the neurotechnology market dynamics @ Neurotechnology Market Trends

Regional Neurotechnology Market Insights

North America

• North America is projected to hold the largest share of the global neurotechnology market, accounting for approximately 39% in 2025. 
• The region’s market leadership is supported by its well-established healthcare infrastructure, the strong presence of industry leaders such as Neuralink, Medtronic, and Abbott, and substantial investments in research and development. 
• Early adoption of advanced technologies, including brain-computer interfaces (BCIs), favorable regulatory frameworks, and the growing prevalence of neurological disorders further contribute to the increasing demand for innovative neurotechnology solutions across the region.
• The North American neurotechnology market is also being driven by continuous advancements in brain monitoring technologies and BCI systems, coupled with rising investments in neurotechnology startups. 
• Innovations such as high-resolution neural recording platforms, closed-loop neurostimulation systems, and minimally invasive BCIs are enhancing the accuracy of diagnosis and enabling real-time treatment of neurological conditions. 
• These technological developments are improving patient outcomes while broadening the application of neurotechnology in the management of disorders, including epilepsy, Parkinson’s disease, paralysis, and stroke rehabilitation.
• Furthermore, robust venture capital funding and strategic investments from leading healthcare and technology companies are accelerating innovation, supporting clinical research, and facilitating the commercialization of new neurotechnology products across the United States and Canada. As a result, North America continues to strengthen its position as a global center for neurotechnology innovation and market growth.

Europe

• The European neurotechnology market is experiencing robust and consistent expansion, fueled by the growing burden of neurological disorders, rising healthcare expenditures, and the increasing integration of advanced neurostimulation, brain monitoring, and neuroimaging technologies across clinical and research settings. 
• Market growth is also being strengthened by a supportive regulatory environment and substantial public investment through initiatives such as Horizon Europe, which are driving innovation in brain-computer interfaces, neurodiagnostic technologies, and digital neurology platforms.

Asia-Pacific

• The Asia-Pacific region is becoming a significant engine of growth for the neurotechnology market, supported by the rising incidence of neurological disorders, ongoing improvements in healthcare infrastructure, and increasing investments in advanced medical technologies across major economies such as China, Japan, India, and South Korea. 
• Demand for neurodiagnostic and neurostimulation technologies is growing rapidly due to the region’s large patient population suffering from conditions including epilepsy, Parkinson’s disease, stroke, and dementia, coupled with greater awareness of the importance of early diagnosis and timely treatment. 
• Market expansion is further fueled by government initiatives aimed at strengthening healthcare systems, the increasing integration of AI-powered brain monitoring solutions, and the expanding presence of global neurotechnology companies across APAC. 
• Japan and South Korea continue to lead advancements in neuroimaging and brain-computer interface research, while China and India are witnessing substantial growth in the adoption of neurotechnology within hospitals, driven by improved healthcare accessibility and an increasing burden of neurological diseases. 
• In addition, the region benefits from cost-efficient manufacturing capabilities, a growing number of clinical trials, and rising venture capital investments in medtech startups, positioning APAC as an increasingly important center for neurotechnology innovation, development, and commercialization.

To know more about why North America is leading the market growth in the neurotechnology market, get a snapshot of the Neurotechnology Market Share

Recent Developmental Activities in the Neurotechnology Market

• In June 2026, NeuroLife was introduced as a non-invasive neurotechnology company focused on developing wearable solutions that aid rehabilitation for individuals recovering from stroke or living with spinal cord injuries. Serving as the commercial brand of ActivateNeuro, Inc., NeuroLife was established through a strategic collaboration between Battelle and The NeuroTech Institute (NTI).
• In May 2026, Neurosoft Bioelectronics, a neurotechnology company focused on developing scalable, soft brain-computer interfaces (BCIs), announced the successful completion of an oversubscribed seed funding round, raising $7.5 million.
• In May 2026, ABILITY Neurotech secured Investigational Medical Device Dossier (IMDD) approval from the Netherlands’ Medical Research Ethics Committee (MREC) NedMec, paving the way for the first chronic implantation study of its fully implantable, wireless optical-link ECoG brain-computer interface (BCI) in patients with amyotrophic lateral sclerosis (ALS).
• In April 2026, Neurable, a pioneer in AI-powered noninvasive brain-computer interface (BCI) technology, announced its transition to a licensing platform model, enabling global OEM partners to seamlessly incorporate its production-ready BCI technology into consumer wearable devices. This strategic shift represents a significant milestone for both the company and the broader BCI industry, reinforcing Neurable’s commitment to accelerating the adoption of cognitive-enabled consumer products and driving their large-scale commercialization.
• In April 2026, Motif Neurotech, a brain-computer interface (BCI) company focused on advancing mental health technologies, received approval from the FDA for an Investigational Device Exemption (IDE) to initiate the RESONATE Early Feasibility Study.
• In March 2026, China approved the world’s first commercial brain-computer interface medical device, highlighting the transition of neurotechnology from experimental stages to real-world deployment.
• In November 2025, Synchron secured a $200 million Series D funding round to accelerate the commercialization of its Stentrode BCI platform, while also raising over $300 million in total funding to advance BCI innovation.
• In June 2025, Neuralink raised $650 million to support brain implant research and clinical trials, followed by a $650 million Series E in April 2026 to further expand development and global reach.

What is Neurotechnology?

Neurotechnology refers to the broad range of technologies designed to understand, monitor, interact with, or influence the nervous system, particularly the brain. It combines advances in neuroscience, engineering, artificial intelligence, and computer science to develop tools that can record neural activity, stimulate specific regions of the brain or nerves, and translate brain signals into actionable outputs. Applications of neurotechnology span healthcare, research, and consumer markets, including brain-computer interfaces (BCIs), neurostimulation devices, neuroimaging systems, wearable brain-monitoring devices, and digital therapeutics. These innovations are transforming the diagnosis and treatment of neurological disorders such as Parkinson’s disease, epilepsy, stroke, chronic pain, and depression, while also enabling new possibilities in cognitive enhancement, rehabilitation, communication, and human-machine interaction. As the field continues to evolve, neurotechnology is expected to play an increasingly important role in personalized medicine and the future of human health and performance.

Neurotechnology Market Assessment

• Neurotechnology Market Segmentation
  • Neurotechnology Market Segmentation By Product Type: Neurostimulation Devices {Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others}, Neuroprosthetics, Brain-Computer Interface (BCI) Systems, and Neuroimaging Systems
  • Neurotechnology Market Segmentation By Application: Epilepsy, Parkinson’s, Alzheimer’s, Sleep Disorders, and Others
  • Neurotechnology Market Segmentation By End-Users: Hospitals, Homecare, Rehabilitation Centers, and Others
  • Neurotechnology Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL‘s Views, Analyst‘s View

Which MedTech key players in the neurotechnology market are set to emerge as the trendsetter explore @ Neurotechnology Market Analysis

Table of Contents 

Interested in knowing the neurotechnology market share by 2034? Click to get a snapshot of the Neurotechnology Market Size

Related Reports

Neurostimulation Devices Market

Neurostimulation Devices Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key neurostimulation devices companies, including Abbott Laboratories, Smith’s Medical, B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., LivaNova PLC., Medtronic, Nevro Corp., Abbott, Stryker, Omron Corporation, Stimwave LLC, Koninklijke Philips NV, Kimberly Clark Corporation, EndoStim Inc., Aleva neurotherapeutics SA, Cyberonics, DyAnsys, Inc., NanoVibronix, Inc., ElectroCore Inc., and others.

Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key deep brain stimulation devices companies, including Abbott Laboratories, Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics, Renishaw plc, NeuroPace, Inc., NeuroSigma, Inc., Elekta, LivaNova PLC, SceneRay Co., Ltd., Synapse Biomedical, BrainsWay, Magstim, Newronika S.p.A., Brainlab AG, Functional Neuromodulation, Ltd., Theranica Bio-Electronics Ltd., Precisis GmbH, Neuros Medical, Magnus Medical, Inc., and others.

Implanted Brain-Computer Interface Devices Market

Implanted Brain-Computer Interface Devices Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key implanted BCI devices companies, including NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.

Spinal Cord Stimulators Market

Spinal Cord Stimulators Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord stimulators companies, including Boston Scientific Corporation, Medtronic, Abbott, Nevro Corp, Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us
Shruti Thakur
[email protected]
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-neurotechnology-market-is-projected-to-cross-usd-50-billion-by-2034–delveinsight-302818137.html

SOURCE DelveInsight Business Research, LLP